• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Cannabis extract trial for epilepsy and severe autism

natasa778

Senior Member
Messages
1,774
http://www.telegraph.co.uk/finance/...based-treatments-could-be-used-in-autism.html

... The British drugmaker, which develops medicines using cannabis extracts, is putting together the "building blocks" of a research programme into autism, its chief executive told The Telegraph.

Justin Gover said doctors treating severely epileptic children with GW's experimental drug Epidiolex had observed improvements in behaviour and brain function in those patients who also had autism.

He cautioned that the observations were "no more scientific at this stage" but that he saw an "important role for GW in researching the use of cannabinoids within autism-like disorders".

GW has been testing Epidiolex in a few dozen children with debilitating forms of epilepsy in the US for around a year and has already seen "promising" results. It has done so under a so-called "expanded access" programme which allows patients with untreatable conditions to try out experimental drugs.


...
Analysts have previously suggested that Epidiolex could also be used in autism since the two conditions are closely associated. As many as a third of people on the autistic spectrum also have epilepsy...